Table 1.
Datasets used in this study.
| Abbreviation | TCGA primary | TCGA metastatic | ICGC | Cancer name |
|---|---|---|---|---|
| ACC | 79 | 0 | 0 | Adrenocortical carcinoma |
| BLCA | 414 | 0 | 0 | Bladder urothelial carcinoma |
| BRCA | 1102 | 7 | 50 | Breast invasive carcinoma |
| CESC | 304 | 2 | 0 | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
| CHOL | 36 | 0 | 0 | Cholangiocarcinoma |
| COAD | 478 | 1 | 0 | Colon adenocarcinoma |
| DLBC | 48 | 0 | 107 | Lymphoid neoplasm diffuse large B-cell lymphoma |
| ESCA | 161 | 1 | 0 | Esophageal carcinoma |
| GBM | 156 | 0 | 0 | Glioblastoma multiforme |
| HNSC | 500 | 2 | 40 | Head and neck squamous cell carcinoma |
| KICH | 65 | 0 | 0 | Kidney chromophobe |
| KIRC | 538 | 0 | 136 | Kidney renal clear cell carcinoma |
| KIRP | 288 | 0 | 0 | Kidney renal papillary cell carcinoma |
| LAML | 151 | 0 | 323 | Acute myeloid leukemia |
| LGG | 511 | 0 | 0 | Brain lower grade glioma |
| LIHC | 371 | 0 | 606 | Liver hepatocellular carcinoma |
| LUAD | 533 | 0 | 0 | Lung adenocarcinoma |
| LUSC | 502 | 0 | 0 | Lung squamous cell carcinoma |
| MESO | 86 | 0 | 0 | Mesothelioma |
| OV | 374 | 0 | 111 | Ovarian serous cystadenocarcinoma |
| PAAD | 177 | 1 | 389 | Pancreatic adenocarcinoma |
| PCPG | 178 | 2 | 0 | Pheochromocytoma and paraganglioma |
| PRAD | 498 | 1 | 169 | Prostate adenocarcinoma |
| READ | 166 | 0 | 0 | Rectum adenocarcinoma |
| SARC | 259 | 1 | 57 | Sarcoma |
| SKCM | 103 | 367 | 0 | Skin cutaneous melanoma |
| STAD | 375 | 0 | 0 | Stomach adenocarcinoma |
| TGCT | 150 | 0 | 0 | Testicular germ cell tumors |
| THCA | 502 | 8 | 0 | Thyroid carcinoma |
| THYM | 119 | 0 | 0 | Thymoma |
| UCEC | 551 | 0 | 0 | Uterine corpus endometrial carcinoma |
| UCS | 56 | 0 | 0 | Uterine carcinosarcoma |
| UVM | 80 | 0 | 0 | Uveal melanoma |
| Sum | 9911 | 393 | 1988 | Sum of all cancers |